Menu
Not yet recruiting NCT07714408

The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities

No phase Interventional Healthy Adults

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mobile-based Acceptance and Commitment Therapy (ACT) program, Document-based Acceptance and Commitment Therapy (ACT) Program.
Who it may be relevant to
Registry conditions: Healthy Adults. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities: A Randomized Controlled Trial Study

Overview

The aim of this study is to investigate whether a smartphone-based Acceptance and Commitment Therapy (ACT) program can improve the mental health and quality of life of care workers in long-term care facilities. The research question of this study is as follows: Among caregivers working in long-term care facilities, are there differences in mental health, quality of life, and job burnout between the experimental group that participated in a smartphone-based ACT program and the control group that participated in a document-based ACT program? Participants in the experimental group will complete 70 daily sessions of a smartphone-based ACT program using Anzeilax-Plus, administered Monday through Friday over a 14-week period. Participants in the control group will complete 70 daily assignments from a document-based ACT program, administered Monday through Friday over the same 14-week period.

Interventions

  • Other Mobile-based Acceptance and Commitment Therapy (ACT) program
    Participants will complete a daily Acceptance and Commitment Therapy (ACT) session through a mobile application on their smartphones.
  • Other Document-based Acceptance and Commitment Therapy (ACT) Program
    Participants will complete a daily Acceptance and Commitment Therapy (ACT) session using materials provided by the research team.

Primary outcome measures

  • Depressive symptoms [Time frame: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)]
  • Anxiety [Time frame: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)]
  • Stress [Time frame: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)]
  • Self-esteem [Time frame: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)]
  • Job burnout [Time frame: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)]
  • Quality of life (Psychological and physical well-being) [Time frame: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)]

Eligibility criteria

Inclusion criteria

  • Caregivers aged 18 years or older who provide care services to older adults in long-term care facilities, own a smartphone, and have no history of depression or other mental illnesses.

Exclusion criteria

  • Caregivers with a history of depression or other mental illnesses, or those who do not own a smartphone.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07714408 · SMWU-2604-HR-020-01 · RS-2026-25477485

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗